Advertisement Teva launches generic Lexapro tablets - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Teva launches generic Lexapro tablets

Teva Pharmaceutical Industries has launched Escitalopram Oxalate Tablets, the generic version of Lexapro tablets.

Escitalopram Oxalate Tablet is the generic version of Forest Laboratories’ depression and generalized anxiety disorder treatment tablets.

Teva has received a 180-day period of marketing exclusivity as it is the first company to file an abbreviated new drug application(ANDA) containing a paragraph IV certification for the product.

The brand product had annual sales of approximately $2.9bn in the US, based on IMS sales data.